CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- 4 Open-market sale COO & CBO sold 5,700 shares at an average $24.44 ($139,330)
- 4 Open-market sale COO & CBO sold 5,700 shares at an average $24.03 ($136,956)
- 4 Open-market sale COO & CBO sold 5,700 shares at $24.83 ($141,506)
- 4 Open-market sale COO & CBO sold 5,700 shares at $26.00 ($148,223)
- 4 Open-market sale COO & CBO sold 5,700 shares at $28.87 ($164,554)
- 4 Open-market sale Chief Medical Officer sold 43,166 shares at an average $32.75 ($1,413,654)
- 4 Open-market sale COO & CBO sold 5,700 shares at $33.33 ($189,987)
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 11 of 16 · 305 filings